Literature DB >> 3951022

Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.

M Chamorro, C Aubert, M Brahic.   

Abstract

We used in situ hybridization and immunocytochemistry to look for a correlation between virus expression and white matter lesions during late demyelinating disease due to persistent Theiler's virus infection. We found the following. (i) Tissue lesions developed at the site of virus infection. This correlation was not explained by infection of lymphocytes and macrophages. (ii) Large differences in the extent of pathology existed between mice. The amount of inflammation paralleled the number of cells containing viral RNA or viral capsid antigens. (iii) C57BL/6 mice, which are resistant to demyelination, were able to eradicate the infection. Our results are strongly in favor of a mechanism of demyelination in which viral gene products play a central role.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951022      PMCID: PMC252831     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Simultaneous in situ detection of viral RNA and antigens.

Authors:  M Brahic; A T Haase; E Cash
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Theiler's virus-induced demyelination: prevention by immunosuppression.

Authors:  H L Lipton; M C Dal Canto
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

4.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

5.  The effect of short-term and chronic immunosuppression on Theiler's virus demyelination.

Authors:  R P Roos; S Firestone; R Wollmann; D Variakojis; B G Arnason
Journal:  J Neuroimmunol       Date:  1982-06       Impact factor: 3.478

6.  Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice.

Authors:  E Cash; M Chamorro; M Brahic
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

7.  Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

8.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus.

Authors:  H L Lipton; M C Dal Canto
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Identification of resident macrophages in renal medullary and cortical interstitium and the juxtaglomerular complex.

Authors:  D A Hume; S Gordon
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  41 in total

1.  L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line.

Authors:  M Obuchi; J Yamamoto; T Odagiri; M N Uddin; H Iizuka; Y Ohara
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.

Authors:  L Zhou; Y Luo; Y Wu; J Tsao; M Luo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

5.  Role of the humoral immune response in resistance to Theiler's virus infection.

Authors:  C P Rossi; E Cash; C Aubert; A Coutinho
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.

Authors:  M Yamada; A Zurbriggen; R S Fujinami
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

7.  Innate but not adaptive immune responses contribute to behavioral seizures following viral infection.

Authors:  Nikki J Kirkman; Jane E Libbey; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

Review 8.  Neuroimmune interactions in a model of multiple sclerosis.

Authors:  C Jane Welsh; Andrew J Steelman; Wentao Mi; Colin R Young; Ralph Storts; Thomas H Welsh; Mary W Meagher
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

9.  Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens.

Authors:  Zhiguo Liang; A S Manoj Kumar; Morris S Jones; Nick J Knowles; Howard L Lipton
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.